Shanghai, China

Shaoyu Xu


 

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovator Spotlight: Shaoyu Xu

Introduction

Shaoyu Xu is a prominent inventor based in Shanghai, China, with a notable contribution to the field of biomedicine. With a total of three patents to his name, Xu's work primarily focuses on developing innovative solutions for cancer treatment, particularly through the exploration of PD-L1 antibody technology.

Latest Patents

One of Shaoyu Xu's latest patents includes the detailed invention relating to a PD-L1 antibody, antigen-binding fragments thereof, and medical applications thereof. This significant invention encompasses chimeric and humanized antibodies that are then used in a pharmaceutical composition aimed at fighting cancer. The essence of this invention lies in its application as a humanized PD-L1 antibody for the creation of medicaments treating PD-L1 mediated diseases or disorders. Xu's innovative approach highlights the crucial role of PD-L1 antibodies as potential anti-cancer drugs.

Career Highlights

Shaoyu Xu has worked with leading organizations in the pharmaceutical sector, such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work with these companies demonstrates a strong foundation in research and development, focusing on translating scientific discoveries into real-world applications that improve patient outcomes.

Collaborations

Throughout his career, Shaoyu Xu has collaborated with esteemed colleagues, including Xiangdong Qu and Qiyue Hu. These partnerships have been instrumental in advancing his research endeavors and contributing to the innovative environment in which he thrives.

Conclusion

Shaoyu Xu stands out as an influential inventor in the realm of cancer research, with his patents reflecting a deep commitment to developing effective medical solutions. His innovative endeavors continue to inspire advancements in the biomedical field, making a significant impact on the treatment of diseases associated with PD-L1.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…